Hydration and allopurinol or rasburicase are used for treatment of hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia (ie, a tumor lysis syndrome) caused by the rapid lysis of leukemic cells during initial therapy in AML.